Limit Mix-Ups With Meds for Crohn Disease

March 2026

You’ll see more “advanced therapies” used up front to manage moderate to severe Crohn disease.

Crohn disease is a type of inflammatory bowel disease that leads to abdominal pain, diarrhea, etc.

Previously, patients would start with early use of biologics, such as infliximab (Remicade) or adalimumab (Humira)...with or withOUT immunomodulators (azathioprine, etc).

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 120+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote